51 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
capabilities. There are risks involved with establishing our own sales, marketing, distribution, training and support capabilities. For example, recruiting … and training sales and marketing personnel is expensive and time consuming and could delay our ability to focus on other priorities. If the commercial
6-K
EX-99
BLRX
Bioline Rx Ltd
30 Aug 23
Current report (foreign)
6:45am
; and
BioLine shall, upon Licensee’s reasonable request, provide reasonable technical assistance (including without limitation, on-site training) at Licensee’s … provide appropriate training and education to anyone performing work on their behalf under this Agreement on all applicable anti-bribery/anti
6-K
EX-99
BLRX
Bioline Rx Ltd
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
the University of Connecticut Health Center and her B.Sc. degree from Fairfield University in biology. Dr. Bormann completed postdoctoral training … of Science, and his B.Sc. degree in chemistry and physics from the Hebrew University of Jerusalem. Dr. Hofstein completed postdoctoral training at Harvard
6-K
EX-99
BLRX
Bioline Rx Ltd
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
completed postdoctoral training at Yale Medical School in the department of pathology.
Raphael Hofstein, Ph.D.
Dr. Hofstein has served on our Board … Institute of Science, and his B.Sc. in chemistry and physics from the Hebrew University in Jerusalem. Dr. Hofstein completed postdoctoral training
6-K
EX-99
sk1q3nm21xpbyk myqa
15 Dec 21
BioLineRx Announces Formation of Immuno-Oncology
7:25am
6-K
EX-99
4h1s2317zw1wm611l03k
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-99
2ec3dy
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-1
5ql y9xqhkz
28 May 19
Current report (foreign)
7:04am